The saga of the prematurity-prevention drug Makena and the outrage over its pricing continues: on Friday, the maker of the drug, a subsidiary of KV Pharmaceutical, announced it would reduce its price 55%, from $1,500 to $690 per dose.
KV Pharmaceutical’s Makena, a new brand of an old drug to prevent premature birth, went on sale last week at an exponentially increased price — going from about $10-$20 per dose to $1,500, and inviting widespread criticism and scrutiny.
Lauren Fleming was born 3½ months early and weighed just a smidge over 2 lbs. When her mother, Nikki Fleming, got pregnant again, her doctor administered weekly progesterone injections. Fleming’s next two children, Erin and …